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Abstract
Previously, we have documented that isolated autophagosomes from tumor cells could efficiently cross-prime tumor-
reactive naı¨ve T cells and mediate tumor regression in preclinical mouse models. However, the effect of tumor-derived
autophagosomes, here we refer as to DRibbles, on B cells has not been studied so far. At present study, we found that
DRibbles generated from a murine hepatoma cell line Hep1-6, induced B-cell activation after intravenous injection into
mice. B-cell populations were significantly expanded and the production of Hep1-6 tumor-specific antibodies was
successfully induced. Moreover, in vitro studies showed that DRibbles could induce more efficient B-cell proliferation and
activation, antibody production, and cytokine secretion than whole tumor cell lysates. Notably, we found that B-cell
activation required proteins but not DNA in the DRibbles. We further showed that B cells could capture DRibbles and
present antigens in the DRibbles to directly induce T cell activation. Furthermore, we found that B-cell activation, antibody
production, cytokine secretion and antigen cross-presentation were TLR2-MyD88 pathway dependent. Taken together, the
present studies demonstrated that tumor-derived autophagosomes (DRibbles) efficiently induced B cells activation,
antibody production, cytokine secretion and antigen cross-presentation mainly depending on their protein component via
TLR2/MyD88 dependent manner.
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Introduction
Autophagy is a cellular process in which portions of the
cytoplasm are sequestered by double membrane vesicles termed
autophagosomes [1]. With induction of autophagy and inhibition
of lysosomal/proteasome activity, a broad spectrum of cellular
antigens, including long-lived proteins, short-lived proteins, and
defective ribosomal products (DRiPs), is sequestered in autopha-
gosomes. These autophagosome enriched with DRiPs-containing
blebs are termed DRibbles [2]. Our previous studies have shown
that DRibbles are efficient carriers of protein antigens from tumor
cells and tumor associated antigens encapsulated in the DRibbles
could be captured by dendritic cells (DCs) and cross-presented to
T cells [2–5].
B cells can recognize and respond to both soluble and
membrane-associated antigens via specific B cell receptor (BCR)
[6,7]. Recent studies show that B cells express most Toll like
receptors (TLRs) and can respond to a variety of TLR ligands
[8,9]. Following these stimuli, B cells can proliferate and
differentiate into antibody secreting cells, becoming more efficient
antigen-presenting cells or cytokine producer cells [10]. Antibodies
are the first line defense against infection and most vaccines work
because they elicit a protective antibody response. Therefore, it is
highly desirable for vaccine to be able to induce strong B cell and
T cell mediated adaptive immune responses. In addition to their
role in humoral immunity, B cells are important professional
antigen presenting cells (pAPCs) and in certain circumstance they
are very efficient pAPCs for antigen cross-presentation [11,12].
For the novel vaccines based on tumor-derived DRibbles, there is
no available information concerning their effect on B cell function.
In this study, we examined whether tumor-derived DRibbles
could induce B-cell activation and proliferation and production of
tumor-specific antibodies in vivo. If so, we also set out to
determine the molecular pathways by which DRibbles induce B-
cell activation. Finally, we investigated whether B cells could
uptake and cross-present DRibbles antigens and serves as efficient
antigen presenting cells for T cell activation.
Results
DRibbles Induced Tumor Specific Antibody Production
in vivo
To examine whether DRibbles could induce antibody pro-
duction in vivo, C57/BL6 mice were injected intravenously with
DRibbles derived from a murine hepatoma cell line (Hep 1-6)
and then serum samples were collected at day 7 after first
injection of DRibbles. ELISA analysis showed that levels of total
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serum IgM and IgG were significantly increased after injection
with DRibbles comparing with PBS injection (Figure 1A and
B). To further determine whether DRibbles-induced antibodies
were specific to the antigens expressed by tumor cells, Hep1-6
or control cell line B16F10 cells were incubated with serum
collected from Hep1-6/DRibbles-injected mice respectively, and
then were stained with FITC-labeled anti-mouse IgM or IgG
antibodies. Flow cytometric analysis showed that both IgM and
IgG induced by Hep1-6 DRibbles were able to specifically stain
Hep1-6 cells but not to B16F10 cells (Figure 1C and D).
Consistently, immuno-uorescent microscopy also confirmed that
IgM and IgG specifically stained to Hep1-6 cells, but not to
B16F10 cells (Figure 1E and F). Subsequently, both reactivity
and specificity of antibodies induced by Hep1-6/DRibbles were
further detected by ELISA. It was found that the antibodies in
the sera from Hep1-6 DRibbles-injected mice could react to
Hep1-6 cells lysate, but not lysates of B16F10 cells or BNL cells
compared with the control sera from PBS-injected mice (Figure
S1). Thus, these results indicated that DRibbles derived from
tumor cells could induce tumor antigen-specific IgM and IgG
secretion in vivo.
DRibbles Induced B cell Activation and Proliferation
in vivo
To determine whether DRibbles-induced IgM and IgG
production resulted from B cell activation, splenocytes were
harvested from DRibble-injected mice, both frequencies and
absolute numbers of B cells in the spleen were measured by
flow cytometric analysis. Results showed that the percentage of
B220+ B cells among total splenocytes was markedly increased
after administration of DRibbles (Figure 2A). The total number
of splenocytes or splenic B cells (B220+ cells) was significantly
increased after injection of DRibbles comparing with PBS
injection (Figure 2B). The activation status of B cells is
commonly characterized by the expression of various activation
markers, including the major histocompatibility complex
(MHC), CD86 and CD40 [13,14]. Flow cytometric analysis
further revealed that the expression of MHC class I molecule
(H-2Kb), MHC class II molecule (I-Ab), and co-stimulatory
molecules (CD86 and CD40) on B cells was up-regulated after
injection with DRibbles (Figure 2C). Taken together, these
Figure 1. DRibbles derived from tumor cells induce specific antibody production in vivo. (A and B) Serum was collected from C57/BL6
mice at day 7 after first intravenous injection of PBS or Hep1-6 derived DRibbles (DRs). The total IgM (A) and IgG (B) in serum was measured by ELISA.
Values are the mean 6 SEM derived from three mice per group (n = 3). (C and D) Hep1-6 or B16F10 cells were incubated for 1 hour with serum
derived from PBS or Hep1-6 DRibbles injected mice respectively. After washing, Hep1-6 or B16F10 cells were incubated with FITC-labeled anti-mouse
IgM antibody (C) or FITC-labeled anti-mouse IgG antibody (D). After washing, the cells were analyzed by flow cytometry. (E and F) HepI-6 or B16F10
cells were treated as C and D, and then the cells were stained with DAPI and analyzed by fluorescence microscope. Green fluorescence represents
FITC-labeled anti-mouse IgM antibody (E) or FITC-labeled anti-mouse IgG antibody (F). Blue fluorescence represents the cell nucleus. A representative
of three independent experiments was showed.
doi:10.1371/journal.pone.0053564.g001
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results indicated that DRibbles could induce B cells activation
and proliferation in vivo.
DRibbles Directly Induced B cell Proliferation and
Activation in vitro
B cell responses to most protein antigens require the activation
of DCs and the recruitment of Ag-specific Th cells [15]. To further
examine whether DRibbles or whole tumor cell lysate could
stimulate B cell proliferation directly, B cells purified from naive
mice were labeled with CFSE and incubated with DRibbles or
tumor cell lysate for 5 days respectively. Flow cytometric analysis
showed that DRibbles alone, similar to LPS, were higher potent at
stimulating B cell proliferation than tumor lysate. Under our
experimental condition, 31.6% of B cells were divided after
stimulation with DRibbles and LPS caused 40.9% B cells to
divide. In sharp contrast, tumor lysate at an equivalent protein
concentration barely stimulated 7.1% B cells undergoing divisions
(Figure 3A). To evaluate the direct effect of DRibbles on B cell
activation, we cultured B cells in the presence of DRibbles for 72
hours and measured the expression of MHC molecules and co-
stimulatory molecules on B cells by flow cytometric analysis. As
expected, treatment with DRibbles significantly up-regulated the
expression of MHC class I molecule (H-2Kb), MHC class II
molecule (I-Ab), and co-stimulatory molecules (CD86 and CD40)
on B cells (Figure 3B).
To determine whether DRibbles can induce antibody pro-
duction by activated B cells in vitro, we cultured splenocytes and
purified B cells in the presence of DRibbles or whole tumor cell
lysate, and harvested the culture supernatants at day 7 for ELISA
analysis of secreted antibodies. Results showed that stimulation of
the splenocytes in vitro with DRibbles induced much higher levels
of IgM secretion than with tumor lysate (Figure 3C). Moreover,
in the absence of accessory cells, such as DCs and macrophages,
the purified B cells could be stimulated by DRibbles to secrete
significant higher levels of IgM secretion than that by tumor lysate
(Figure 3D). Surprisingly, DRibbles did not increase the IgG level
in the culture supernatants over that of control without stimulation
(data not shown). These results showed that DRibbles, as a source
of tumor antigens, were more efficient at activating B cells than
whole tumor cell lysate.
Apart from antibody secretion, B cells are known to produce
a wide range of cytokines, including IL-6, IL-10 and TNF-
a [16,17]. Next, we investigated whether DRibbles could also
activate B cells to secrete pro-inflammatory cytokines. The purified
B cells were cultured with DRibbles or whole tumor cell lysate for
72 hours, and the supernatants were harvested for cytokine
detection. ELISA analysis showed that DRibbles stimulation,
similar to LPS, could significantly increase the levels of IL-6, IL-10
and TNF-a, whereas whole tumor cell lysate stimulation could not
(Figure 3E). However, very little IL-2 and IL-12, and no IFN-c
Figure 2. DRibbles induced proliferation and activation of B cells in vivo. (A and B) C57/BL6 mice were intravenously injected with DRibbles
(DRs) or PBS as the control for 3 times in day 1, 2 and 3. Splenocytes were collected from each mouse in day 4 after first injection and were stained
with anti-mouse B220 mAb. The percentage of B220+ cells in splenocytes (A) and total number of splenocytes and B220+ cells from each mouse (B)
were analyzed by flow cytometry (n = 5). (C) Splenocytes from each mouse were stained with anti-mouse B220 mAb and the indicated mAbs
respectively. The expression of H2-Kb, I-Ab, CD40 and CD86 of B220+ gated cells was analyzed by ow cytometry. Gray shaded histograms indicate the
isotype staining. Results represent three independent experiments.
doi:10.1371/journal.pone.0053564.g002
DRibbles Induce B Cell Activation
PLOS ONE | www.plosone.org 3 January 2013 | Volume 8 | Issue 1 | e53564
and IL-4 were detected when B cells were stimulated with
DRibbles alone (Figure S2). These data demonstrated that
DRibbles had a marked effect on the IL-6, IL-10 and TNF-
a secretion of B cells.
B cell Activation Requires Proteins, Not DNA, in DRibbles
To test whether proteins or DNA contained in DRibbles
cause B cell activation, we digested DRibbles with DNase I or
proteinase K before they were used to stimulate B cells. Agarose
gel electrophoresis showed that DNA in DRibbles was
completely degraded upon digestion with DNase I
(Figure 4A). Similarly, analyses by SDS-PAGE showed that
proteins in DRibbles were completely degraded upon digestion
with proteinase K (Figure 4B). Fluorescence microscopic
examination showed that the membrane structure of DRibbles
was not damaged when DRibbles was digested with DNase or
Proteinase. CFSE-labeled DRibbles-proteins were completely
eliminated by proteinase treatment, while Dil-labeled DRibbles-
membrane remained intact. DNase treatment did not have any
effect on either protein or membrane (Figure 4C). Sub-
sequently, the purified B cells were incubated with digested or
undigested DRibbles for 72 hours. Flow cytometric analysis
showed that the expression of I-Ab and CD86 on B cells were
still up-regulated when B cells were stimulated by DRibbles
digested with DNase I, to a similar levels up-regulated by
control DRibbles without digestion (Figure 4D), indicating that
removal of DNA in DRibbles had no effect on B cell activation.
By contrast, B cells failed to up-regulate the expression of I-Ab
and CD86 when stimulated with proteinase-digested DRibbles
(Figure 4E). In addition, ELISA analyses showed that there
was no significant difference in the IL-6 and IL-10 secretion of
Figure 3. DRibbles induced proliferation and activation of B cells in vitro. (A) Purified B cells were labeled with CFSE and then co-incubated
with DRibbles (DRs), whole tumor cell lysate (Lys) or LPS for 5 days. The proliferation of B cells was accessed by flow cytometry. (B) Purified B cells
were co-incubated with DRibbles for 3 days and collected for staining with the indicated Abs or isotype-matched control Abs (gray filled area). The
expression of H2-Kb, I-Ab, CD86 and CD40 on B cells was analyzed by ow cytometry. (C and D) Splenocytes (C) and purified B cells (D) were co-
incubated with DRibbles or lysate respectively for 7 days. IgM in the supernatants was analyzed by ELISA. (E) Purified B cells were co-incubated with
DRibbles, tumor cell lysate or LPS for 3 days. Cytokines including IL-6, IL-10, TNF-aa in the supernatants was analyzed by ELISA. (CM indicated
complete medium). Results represent three independent experiments.
doi:10.1371/journal.pone.0053564.g003
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B cells between undigested DRibbles and DNase-digested
DRibbles stimulation. However, only small amounts of IL-6
and IL-10 were detected when B cells were stimulated with
proteinase-digested DRibbles (Figure 4F). These results dem-
onstrated that DRibbles-induced B cell activation mainly
depended on the proteins, but not DNA component in
DRibbles.
DRibbles Induced B cell Activation via TLR2-MyD88
Dependent Manner
It has been shown that expression of MHC class II molecules
and CD86 molecules on B cells was strongly up-regulated via
TLRs stimulation [18]. In order to determine the role of TLR-
mediated signaling pathways in B cell activation induced by
DRibbles, B cells purified from wild type, TLR4-, TLR2- and
MyD88-deficient mice were examined for MHC class II and
CD86 expression after stimulation with DRibbles. We found that
DRibbles failed to up-regulate I-Ab and CD86 expression on
MyD88- or TLR2-deficient B cells, while TLR4 deficiency did not
affect the up-regulation of I-Ab and CD86 expression on B cells
(Figure 5A). Moreover, ELISA analyses showed that IL-6 and IL-
10 secretion of B cells purified from TLR2- and MyD88-deficient
mice was remarkably reduced compared with B cells from wild
type mice. In contrast, TLR4-defficiency had no significant effect
on IL-6 and IL-10 secretion when B cells were stimulated with
DRibbles (Figure 5B). Interestingly, IgM production of B cells
purified from TLR2- and MyD88-deficient mice, after stimulation
with DRibbles, was markedly decreased when compared with that
of TLR42/2 and normal B cells (Figure 5C). These results
indicated that B-cell activation, antibody production, and cytokine
secretion induced by DRibbles was TLR2-MyD88 dependent.
B cells Could Directly Capture DRibbles in vitro
To investigate whether B cell could take up DRibbles directly, B
cells were purified from the spleens of wild type mice and were
incubated with CFSE-labeled DRibbles. Flow cytometric analysis
showed that the frequency of CFSE-positive B cells was increased
6 hours after incubation and reached the peak level at 12 hours
(Figure 6A). It is estimated that around 33% of B cells captured
DRibbles after 12 hours of incubation. The frequency of CFSE-
positive B cells decreased at 24 hours of incubation, possibly due to
the degradation and disappearance of CFSE-labeled proteins
(Figure 6B). Notably, confocal laser microscopy analysis revealed
that CFSE-labeled DRibbles either attached to B cell membrane
or entered into cytosol of B cells (Figure 6C). These results
demonstrated that DRibbles could be efficiently captured and
internalized by B cells.
To further determine the role of TLRs in the internalization of
DRibbles, B cells purified from wild type, TLR4- and TLR2-
deficient mice were incubated with CFSE-labeled DRibbles for 12
hours. Flow cytometric analyses showed that the capacity of
TLR42/2 B cells to capture DRibbles was similar to that of wild
type B cells, but TLR22/2 B cells showed a lower capturing
capacity (Figure 6D). These results suggested that TLR2 might
be involved in the DRibbles-uptake by B cells.
B cells Could Present DRibbles-contained Antigens and
Re-activated Effector T cells
To examine whether B cells could process and present DRibbles
antigens, we designed antigen cross-presentation experiment
following the rules of MHC restriction, lymphocytes were
harvested from DRibbles vaccinated C57/BL6 or BALB/c mice
and then stimulated with B cells (from C57/BL6 mice) loading
DRibbles (Figure 7A). IFN-c in the supernatant was detected
after 72 hours incubation. ELISA analysis showed that lympho-
cytes from both vaccinated C57/BL6 and BALB/c mice could
secrete IFN-c when stimulated with DRibbles directly. Interest-
ingly, when C57/BL6 B cells were first loaded with DRibbles and
washed away free DRibbles before they were used as APCs, only
effector T cells from C57/BL6 mice but not BALB/c mice could
respond and secrete IFN-c (Figure 7B). These data showed that B
cells could cross-present DRibbles-contained antigens to effector T
cells independent of other accessory cells such as DCs or
macrophages.
To determine the efficiency of cross-presentation of DRibbles-
antigens by B cells, CD8+ T cells and CD4+ T cells were purified
from the DRibbles vaccinated C57/BL6 mice and co-incubated
with DRibbles-loaded DCs or B cells at the indicated ratios.
ELISA analyses showed that DRibbles-loaded B cells induced
IFN-c secretion by CD8+ and CD4+ T cells in a B-cell number
dependent fashion (Figure 7C and D). However, only little IL-4
was detected when CD4+ T cells were co-incubated with B cells
loading DRibbles (Figure 7E). When the same ratio (1:1) was
used, the cross-presentation efficiency between B cells and DCs
appeared comparable. These results demonstrated that B cells
could cross-present DRibbles -contained antigens and re-activate
effector T cells response.
To further determine the role of TLRs in B cells in the cross-
presentation of antigens in the DRibbles, B cells purified from wild
type, TLR4-, TLR2- and MyD88-deficient mice were loaded with
DRibbles and incubated with CD8+ T cells from the DRibbles-
primed C57/BL6 mice. ELISA results showed that IFN-c
secretion of DRibbles-primed CD8+ T cells was greatly reduced
when TLR22/2 and MyD882/2 B cells were used as APC as
compared with WT B cells; whereas TLR4 deficiency in B cells
had a weaker but significant effect on the IFN-c secretion of CD8+
T cells (Figure 7F). These results suggested that the cross-
presentation of antigens in the DRibbles by B cells was dependent
on the TLR2-MyD88 pathway.
Finally, to determine whether the cross-presentation of antigens
in the DRibbles by B cells was capable to stimulate antigen-specific
T cells, DRibbles from Hep1-6, BNL cells, or B16F10 cells were
loaded on B cells and used to re-stimulate Hep1-6/DRibbles
primed CD8+ T cells. ELISA results showed that Hep1-6
DRibbles were efficiently cross-presented by B cells and induced
IFN-c secretion of Hep1-6/DRibbles-primed CD8+ T cells.
However, only little IFN-c release was detected when B cells
were loaded with BNL cells- or B16F10 cells-derived DRibbles
(Figure 7G). Our results suggested that DRibbles-loaded B cells
could stimulate tumor -specific T cell immune response.
Discussion
In this study, we have demonstrated that DRibbles could induce
B cells activation and proliferation, which are consistent with the
recognized function for DRibbles in activating antigen-specific T
cells response [4,5]. More importantly, DRibbles alone could
increase IgM secretion in a T-independent manner in vitro. When
antigens bear repeating determinants expressed at high density
they can also activate specific B cells for further differentiation and
antibody production in a T-independent manner [19]. DRibbles
consisting of multiple epitopes or undefined antigens derived from
tumor cells have given better clinical responses than single peptide
or protein [20]. Similarly, the capacity of DRibbles to increase
IgM secretion is more potent than whole cell lysate in vitro. T cell-
dependent, BCR-driven responses lead to germinal center
formation, affinity maturation, and memory cell differentiation,
DRibbles Induce B Cell Activation
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whereas TLR-driven responses tend toward rapid antibody-
forming cell differentiation with limited affinity maturation and
memory [21]. Here, we found that IgM production of B cells
induced by DRibbles in vitro was dependent on TLR2-MyD88
signaling pathway. Moreover, there was no tumor antigen specific
antibody production in vitro when purified B cells were stimulated
Figure 4. B cells activation was mainly depended on proteins but not DNA in DRibbles. DRibbles (DRs) were digested with DNase I or
proteinase K and then released after lysed with RIPA lysis buffer. (A) The DNA in DRibbles was analyzed via agarose gel electrophoresis. (1. Markers 2.
DRibbles 3. DRibbles digested with DNase I, 4. DRibbles digested with proteinase K). (B) The proteins in DRibbles were analyzed via 12% SDS
polyacrylamide gel electrophoresis. (1. Markers 2. DRibbles 3. DRibbles digested with Proteinase K 4. DRibbles digested with DNase I). (C) DRibbles,
DRibbles digested with DNase I or Proteinase K were stained with both CFSE and DiI. The characteristic of DRibbles was detected by the fluorescent
microscope analysis (green presents CFSE labeled DRibbles-proteins; red presents DiI labeled DRibbles-membrane). (D and E) DRibbles digested with
or without DNase I (D) or proteinase K (E) were co-incubated with purified B cells for 72 hours. B cells were collected and stained with Abs to
corresponding surface markers (indicated), or isotype-matched control Ab (gray filled area). The expression of I-Ab and CD86 on B cells were analyzed
by flow cytometry (blue line indicated complete medium; red line indicated DRibbles; green or pink line indicated DRibbles treated with DNase or
proteinase). (F) B cells were incubated with DRibbles digested with or without DNase I or proteinase K for 72 hours, IL-6 and IL-10 in the supernatants
were detected by ELISA. Results represent three independent experiments.
doi:10.1371/journal.pone.0053564.g004
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with DRibbles (data not shown). However, the antibodies induced
by DRibbles in vivo appeared to be tumor antigen specific. These
results suggested that antibodies production induced by DRibbles
in vitro depended mainly on TLR signaling pathway and these
IgM might be nature antibodies that are not antigen specific,
whereas the cooperation of BCR and TLRs may be required for
antigen-specific antibody production induced in vivo.
B cells are major producers of cytokines such as IL-10, IL-6 and
TNF-a [22–24]. Cytokines are a major component of cellular
microenvironments, where they play a pivotal role in the control of
cell survival, proliferation, and differentiation [25]. Our current
results have revealed that DRibbles significantly enhance IL-10,
IL-6 and TNF-a production by B cells. When stimulated with
effector T cells and antigens, B cells have also been shown to
produce detectable quantities of immune-regulatory cytokines
such as IL-2, IL-12, IFN-c and IL-4 [26–29]. In the current study,
there is little IL-2 and IL-12 secretion when B cells are stimulated
with DRibbles alone. However, no secretion of IFN-c or IL-4 is
detected when B cells are stimulated with DRibbles alone (data not
shown). Recent studies show that IL-10-producing B cells possess
a regulatory function both in vitro and in vivo [30]. Interestingly,
we also found that DRibbles could induce IL-10+ B cells in vivo
(data not shown). Further studies are needed to determine whether
Figure 5. The role of TLR4, TLR2 and MyD88 signaling pathways in B cells activation induced by DRibbles. B cells purified from wild
type, TLR4-, TLR2- or MyD88-deficient mice were co-incubated with DRibbles respectively for 72 hours. (A) B cells was collected and stained with
indicated Abs. The expression of I-Ab and CD86 on B cells were detected by flow cytometer. (B) IL-6 and IL-10 in the supernatants were determined by
ELISA. (C) IgM in the supernatants was determined by ELISA. (WT indicated B cells from wild type mice; TLR4KO, TLR2KO, and MyD88KO indicated B
cells from TLR4-, TLR2- and MyD88-deficient mice). Results represent three independent experiments.
doi:10.1371/journal.pone.0053564.g005
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the cytokines produced by B cells regulate the activity or function
of other cell types, especially T cells in tumor-bearing hosts.
DRibbles enrich a broad spectrum of tumor antigens, including
intact protein, DRiPs and HSP-bound proteins [2]. Certain HSPs,
such as HSP70, Gp96 played a critical role in preserving the
antigen repertoire and up-regulating surface expression of MHC
class II molecule and co-stimulatory molecules such as CD86.
HSPs can activate DCs via TLR2/4 pathway [31]. Our data also
demonstrated that the proteins in DRibbles played an important
role in B cells activation. Recent studies showed that mouse B cells
express TLR1–9, 11 and 13 [32]. TLRs ligation per se can provide
the signals required for B cell proliferation, differentiation, and
antibody secretion [21]. Most TLRs signal requires the adaptor
protein MyD88, which initiate the classical NF-kB cascade
[33,34]. In this study, we found that MHC II and CD86
expression on B cells derived from MyD88 or TLR2 deficient mice
were not up-regulated upon stimulation with DRibbles, while
TLR4 deficiency barely affected B cells activation. Moreover,
MyD88 or TLR2 deficiency severely affected the cytokine
secretion and IgM production of B cells induced by DRibbles
in vitro. Thus, our data have provided new evidence that
DRibbles trigger B cell response via TLR2/MyD88 modulated
manner.
Accumulated data show that B cells internalize antigens via at
least two pathways: nonspecific fluid-phase pinocytosis and
receptor-mediated endocytosis [35–37]. B cells take in the soluble
fluid antigens via nonspecific fluid-phase pinocytosis. Our studies
showed that splenic B cells could capture DRibbles directly.
DRibbles are double-membrane bound vesicles with 300 nm
to1 mm in size [4], it is unlikely that B cells capture DRibbles by
pinocytosis. However, B cells are not considered as phagocytes,
thus DRibbles uptake by B cells are also unlikely mediated by
phagocytosis. Similar to other professional antigen-presenting
cells, B cells express a variety of receptors like BCRs, complement
receptors, FccRs, and TLRs that are involved in the capturing of
potentially antigenic materials [38–43]. Because B cells from
TLR2-deficient mice take up fewer DRibbles than B cells from
wild type mice, it is likely that B cells take up DRibbles through
TLR2-dependent endocytosis pathway. Compared with TLR4,
TLR2 is required for capturing of DRibbles by B cells and
subsequent B cell activation. However, it is currently unknown
whether other receptors such as BCRs, TLR7 and TLR9 affect
internalization of DRibbles in B cells.
In addition to DCs or macrophages, B cells act as pAPC, can
also take up and present T dependent antigens encapsulated in
liposomes or associated with particles [44,45]. When loaded
onto DCs, DRibbles were efficient in activating naive CD8+ T
cells, and DCs loaded DRibbles vaccine has potent antitumor
efficacy [4]. Similarly, we found that B cells loaded DRibbles
can cross-present DRibbles antigens and reactivate effector
CD4+ and CD8+ T cells. B cells might process exogenous
antigen via the class I pathway if antigens are taken up by
receptor-mediated endocytosis [12]. Interestingly, our results
showed that the cross-presentation of DRibbles-antigens by B
cells was mainly dependent on TLR2-MyD88 pathway. Our
results also provided strong evidence that B cells process and
Figure 6. DRibbles can be taken up by B cells in vitro. (A) Purified B cells were co-incubated with CFSE-labeled DRibbles for 6, 12, 24 hours,
CFSE positive B cells were assessed by flow cytometry. (B) The percentage of CFSE positive B cells were counted by flow cytometry as it has been
indicated. (C) B cells taking up DRibbles were detected by the confocal laser microscope analysis. Representative images of immunofluorescence
were stained with PE-conjugated anti-mouse B220 (red) and DRibbles labeled with CFSE (green). Arrows indicated that CFSE-labeled DRibbles were
located inside of B cells. (D) B cells purified from wild type, TLR4- and TLR2-deficient mice were co-incubated with CFSE labeled-DRibbles for 12 hours,
then the CFSE positive B cells were analyzed by flow cytometer. Data represent one of at least three experiments with similar results.
doi:10.1371/journal.pone.0053564.g006
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presented DRibbles-contained antigens via class I pathway, and
predominately induced Th1 response. Previous studies have
shown that DRibbles-loaded DCs vaccine could prime T cells
and induce potent antitumor response [4,5]. Our present results
showed that Dribbles-loaded B cells also could induce T cells
immune response, a process of being independent of DCs.
However, the antitumor efficacy induced by B cells loaded
DRibbles vaccine remains to be determined.
In conclusion, our studies have demonstrated that B cells can
directly capture, process DRibbles and present DRibbles-con-
tained antigen to T cells. DRibbles could induce B cell activation,
antibody production, cytokine secretion in a TLR2/MyD88
modulated manner. Thus, further elucidation of the mechanism
underlying DRibbles-induced B cell activation may facilitate the
development of DRibbles vaccine to enhance antitumor efficacy
in vivo.
Materials and Methods
Ethics Statement
All experimental protocols were approved by the Institutional
Animal Care and Use Committee of Southeast University.
Mice, Cell Lines and Reagents
C57BL/6 and BALB/c female mice were purchased from the
Comparative Medicine Center, Yangzhou University (Yangzhou,
China). TLR4-, TLR2- and MyD88-deficient mice were pur-
chased from the National Resource Center for Mutant Mice
Figure 7. B cells loading DRibbles antigen could re-activate effector T cells. (A) The schematic diagram outlines the experiment protocol.
C57/BL6 mice or BALB/c mice were intro-node vaccinated with DRibbles respectively. Lymphocytes were collected from lymph nodes (LN) of
vaccinated C57/BL6 mice or BALB/c mice on day 7 after immunization. B cells purified from wide type C57/BL6 mice were stimulated with DRibbles
for 6 hours and then washed 3 times with PBS. The lymphocytes were co-incubated with DRibbles or DRibbles-loaded B cells or B cells alone for 72
hours (n = 5). (B) The supernatants were harvested for detection of IFN-c by ELISA. (C) CD8+ T cells were purified from the vaccinated C57/BL6 mice,
and then co-incubated with B cells plus DRibbles (with DCs plus DRibbles at 1:1 ratio or B cell alone as control) at the indicated ratio for 72 hours. IFN-
c in the supernatants was tested via ELISA. (D and E) CD4+ T cells were purified from the vaccinated C57/BL6 mice, and then co-incubated with B cells
plus DRibbles at the indicated ratio for 72 hours. IFN-c (D) and IL-4 (E) in the supernatants were tested via ELISA. (F) CD8+ T cells purified from the
DRibbles-vaccinated C57/BL6 mice were co-incubated at 1:1 ratio with B cells (from wild type, TLR4-, TLR2- or MyD88-deficient mice) plus DRibbles for
72 hours. IFN-c in the supernatants was tested via ELISA. (G) CD8+ T cells were purified from the Hep1-6-DRibbles vaccinated C57/BL6 mice, and then
co-incubated at 1:1 ratio with B cells plus Hep1-6-, B16F10- or BNL-DRibbles for 72 hours respectively. IFN-c in the supernatants was tested via ELISA.
Data which are presented were obtained as a result of triplicates.
doi:10.1371/journal.pone.0053564.g007
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Model Animal Research Center, Nanjing University (Nanjing,
China). All mice were bred and maintained in specific pathogen-
free conditions. Hep1-6 cells derived from the BW7756 hepatoma
that arose in a C57L mouse were purchased from the Institute of
Biochemistry and Cell Biology, Academy of Science (Shanghai,
China). B16F10 melanoma cell line is syngeneic in C57BL/6 mice
and was gifts from Dr. Dou Jun (Department of Microbiology and
Immunology, Medical School of Southeast University, Nanjing,
China) [46]. BNL cell line derived from BNL CL.2 (TIB-75TM)
by transformation with methylcholanthrene epoxide was pur-
chased from ATCC. All the cells were cultured in complete
medium made of RPMI 1640 (Gibico, USA) supplemented with
10% heat-inactivated FCS (Hyclone), 100 U/ml penicillin,
0.1 mg/ml streptomycin (Beyotime Institute of Biotechnology,
Haimen, China). No mycoplasmas or filamentous fungu were
detected in all reagents including DRibbles in the Clinical
Laboratory of the Affiliated Zhongda Hospital of Southeast
University.
Isolation of DRibbles from Hep1-6 Cells
DRibbles were harvested from Hep1-6 cells as described
previously [5]. Tumor cells were treated with 100 nM Rapamycin
(Enzo Life Sciences, Shanghai, China), 100 nM Bortezomib
(Millennium pharmaceuticals, Cambridge, USA), and 10 mM
ammonium chloride in complete medium for 18–24 hours in a 5%
CO2 incubator at 37uC. The cells were harvested and centrifuged
at 1000 rpm. The supernatant was then centrifuged at 12,000 rpm
to harvest the DRibbles. The total amount of protein in DRibbles
was quantified by BCA protein assay Kit according to the
manufacturer’s protocol (Beyotime Institute of Biotechnology,
Haimen, China).
Measurement of DRibbles Induced Tumor-specific Abs
Production
Serum Abs generated in response to tumor cells was evaluated
using an indirect immuno-uorescence assay and flow cytometry.
C57/BL6 mice were injected intravenously (i.v.) with DRibbles
(30 mg total protein) or PBS 3 times at day 1, 2 and 3. Sera were
collected from the orbital sinus of mice at day 7 after first injection
and stored at 220uC. B16/F10 cells and Hep1-6 cells were fixed
in acetone at 4uC for 15 min, blocked in 1% BSA at 37uC for 1
hour, and then incubated with serum (1:200) from DRibbles or
PBS injected mice for 30 min at 4uC. The cells were then washed
extensively, incubated with FITC-conjugated anti-mouse IgG or
IgM Abs (Sigma Aldrich), and analyzed by ow cytometry, or then
the cells were subsequently stained with DAPI (Sigma Aldrich) and
imaged under a uorescence microscope (Nikon-DXM1200, Nikon
Instruments, Inc).
The reactivity of antibodies in the serum from Hep1-6-
DRibbles-injected mice was measured by ELISA. Hep1-6,
B16F10 and BNL tumor cell lysate were coated to plate at
10 mg/ml total proteins concentration overnight at 4uC. After
washing with PBST (PBS plus 0.5% Tween-20), the plate were
blocked with 5% goat serum in PBS for 2 h at 37uC. Then test
serum was diluted serial dilutions and added to the plate for 1 h at
37uC. Subsequently, the antibodies were detected by incubation
with HRP-conjugated anti-mouse IgM or IgG detection antibody
(Jackson ImmunoResearch Laboratories), followed by TMB
substrate solution for development of the ELISA. The optical
density was measured at 450 nm.
B cells activation and proliferation in vivo were tested as
following. C57/BL6 mice were injected intravenously with
DRibbles or PBS as the control for 3 times at day 1, 2 and 3.
Splenocytes were harvested from each mouse at day 4 after first
injection and were stained with APC-labeled anti-mouse B220
mAb, PE-labeled anti-mouse H2-Kb (eBioscience), CD86, CD40
mAb and FITC-labeled anti-mouse I-Ab mAb (BD Bioscience).
Purified anti-mouse CD16/CD32 Ab (BD Bioscience) was used to
block non-specific binding to Fc receptors. Flow cytometric
analysis was performed with an FACS Calibur (BD Bioscience),
and the data was analyzed with Flowjo software (Tree Star). At
least 10,000 live cell events gated by scatter plots were analyzed for
each sample.
B cell proliferation in vitro was assessed by measuring the
dilution of CFSE via flow cytometry. Purified B cells were isolated
by negative selection using a combination of anti-CD43 coupled
magnetic beads as proposed by the manufacturer (Invitrogen). In
all cases, the purity of isolated B cells was $95% by flow
cytometric analysis. Purified B cells from C57/BL6 mice were
labeled with 5 mM of CFSE according to the manufacturer’s
protocol (Invitrogen). CFSE-labeled B cells were co-incubated
with DRibbles or whole tumor cell lysate (10 mg/ml total proteins)
or LPS (10 mg/ml) for 5 days, and then single-cell suspensions
were prepared and analyzed by flow cytometry (FACS Calibur,
BD Bioscience).
Splenocytes were obtained from wild type C57BL/6 or TLR4-,
TLR2- and MyD88-deficient mice. Single-cell suspensions were
generated with cell viability higher than 98%. B cells were purified
and stimulated with or without DRibbles (or whole tumor cell
lysate, 10 mg/ml total proteins; or 10 mg/ml LPS). After 72 hours
incubation, single cell suspensions were collected for detection of
activation markers on B cell surface, and supernatants were
harvested for detection of cytokines including IL-6, IL-10, TNF-a,
IL-12, IL-2, IL-4 and IFN-caccording to the ELISA manufactures
protocol (eBioscience). After 7 days incubation, levels of IgM and
IgG in the supernatants were measured by ELISA.
IgM and IgG Detection by ELISA
ELISA was performed to detect mouse IgM and IgG in serum
samples and cell culture supernatants according to the manufac-
turer’s protocol. Briefly, The plates were coated with either goat
anti-mouse IgG or IgM (Jackson Immuno Research Laboratories)
at 1:10000 overnight at 4uC and washed with ELISA washing
buffer (PBS plus 0.5% Tween-20). Then the plate were blocked
with 2% goat serum in PBS and incubated with serial dilutions of
test sera or cell cultured supernatants. Subsequently, total IgG or
IgM was detected by incubation with HRP-conjugated anti-mouse
IgG detection antibody or HRP-conjugated anti-mouse IgM
detection antibody (Jackson ImmunoResearch Laboratories) re-
spectively, followed by TMB substrate solution (Beyotime Institute
of Biotechnology) for development of the ELISAs. Optical density
was measured at 450 nm.
Characterization of DRibbles Digested with DNase or
Proteinase
DRibbles were digested with DNase I or proteinase K according
to the manufacturer’s protocol (Beyotime Institute of Biotechnol-
ogy), and then washed with PBS; complexes were released after
lysed with RIPA lysis buffer (Beyotime Institute of Biotechnology).
After lysing, treated or untreated DRibbles were centrifuged at
12,000 rpm, DNA or proteins in supernatant were analyzed via
agarose gel electrophoresis or 12%SDS polyacrylamide gel
electrophoresis.
After digestion with DNase I or proteinase K, DRibbles were
stained with CFSE and DiI (Beyotime Institute of Biotechnology)
according to the manufacturer’s protocol respectively. DRibbles
were smeared on the glass slide, and then fixed in acetone at 4uC
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for 15 min; the characteristic of DRibbles was examined with
a uorescent microscope (Nikon-DXM1200).
Internalization and Cross-presentation of DRibbles
Antigens by B cells
DRibbles were labeled with 5 mM CFSE according to the
manufacturer’s protocol (Invitrogen), and then the purified B cells
were co-incubated with CFSE-labeled DRibbles for 6, 12, 24
hours. Single B cells suspension were harvested and stained with
PE-labeled anti-mouse B220 mAb (BD Bioscience), then were
analyzed by flow cytometry and images were collected and
analyzed on a Carl Zeiss confocal station using the LSM510
software (Carl Zeiss MicroImaging,Inc., Germany).
For DRibbles-contained antigens cross-presentation assay,
C57/BL6 mice or BALB/c mice were vaccinated with DRibbles
via intranodal. Lymphocytes were collected from lymph nodes of
DRibbles vaccinated C57/BL6 mice or BALB/c mice, CD8+ T or
CD4+ T cells were purified from above lymphocytes as effector T
cells according to the manufacture’s protocols, respectively
(Invitrogen). B cells were purified from wide type or TLR4,
TLR2, MyD88 deficient C57/BL6 mice and stimulated with
Hep1-6 DRibbles or BNL- or B16F10-DRibbles as control for 6
hours, washed 3 times with PBS. DCs were prepared by sequential
intravenous injection of plasmid DNA encoding murine Flt3L and
GM-CSF as described previously [4]. DRibbles loaded B cells or
DCs were then co-incubated with CD4+T or CD8+T cells at the
indicated ratio for 72 hours. IFN-c or IL-4 in the supernatants was
tested by ELISA according to the manufacturer’s protocol
(eBioscience).
Statistical Analysis
The mean 6S.E.M. was determined for each treatment group
in the individual experiments. Two-tailed t-test was used to
compare treatment groups with the control when significant
differences were observed. Graphpad Prism 5.0 (Graphpad
Software, San Diego, CA) was used for all statistical analysis.
Supporting Information
Figure S1 The antibodies induced by Hep1-6-DRibbles in vivo
reacted specifically with Hep1-6-DRibbles antigens. Hep1-6,
B16F10 or BNL cell lysate were coated in plate, after blocking
and washing, serum from PBS or Hep1-6-DRibbles injected mice
was diluted 200 fold and added to the plate. Subsequently, IgM (A)
and IgG (B) were detected by incubation with HRP-conjugated
anti-mouse IgM or IgG detection antibody, followed by TMB
substrate solution for development of the ELISA. Optical density
was measured at 450 nm. Data represent at least three experi-
ments with similar results.
(TIF)
Figure S2 DRibbles induced little IL-2 and IL-12 secretion of B
cells in vitro. Purified B cells were co-incubated with DRibbles
(DRs), tumor cell lysate (Lys) or LPS for 3 days. Cytokines
including IL-2 (A) and IL-12 (B) in the supernatants was analyzed
by ELISA. (CM indicated complete medium). Results represent
three independent experiments.
(TIF)
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